How do you approach treatment selection for patients with non-small cell lung cancer who have uncommon EGFR mutations compared to those with common mutations?
Community PollStarted
Which treatments do you generally consider utilizing for NSCLC with uncommon EGFR mutations (eg G719X, L861Q, and S768I)?
46 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · University Of Texas Southwestern Medical Center At Dallas
Answered on
In patients with NSCLC, treatment decisions for uncommon EGFR mutations differ significantly from common mutations like exon 19 deletion and L858R. Treatment is personalized based on the specific type of uncommon mutation, which varies in its sensitivity to EGFR tyrosine kinase inhibitors (TKIs).
Fo...
Join for free or sign in to see the full answer